InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-13 | LEVINE JOSHUA | Director | Purchase | 10.0K | $4.22 | $42K | 35.0K | View ↗ |
| Metric | FY2025 | FY2024 |
|---|---|---|
| Total revenues | $11.3M-16.0% | $13.5M |
| Total cost of sales | -$7.1M+17.6% | -$8.7M |
| Gross profit | $30.0M+4.4% | $28.7M |
| Research and development expenses | -$9.7M-15.5% | -$8.4M |
| Selling and marketing expenses | -$27.3M+0.2% | -$27.4M |
| General and administrative expenses | -$17.7M-16.3% | -$15.2M |
| Income (loss) from operations | -$24.7M-11.1% | -$22.2M |
| Financial (expense) income, net | -$3.1M-613.2% | $606K |
| Foreign currency exchange gain (loss), net | -$1.0M-174.4% | $1.3M |
| Loss before taxes | -$28.8M-42.1% | -$20.3M |
| Income tax expense | -$438K-39.9% | -$313K |
| Loss | -$29.2M-42.1% | -$20.6M |
| Basic loss per share | -$0.78-41.8% | -$0.55 |
| Diluted loss per share | -$0.78-41.8% | -$0.55 |
| Basic Weighted average shares outstanding (in shares) | $37.4M+0.4% | $37.3M |
| Diluted Weighted average shares outstanding (in shares) | $37.4M+0.4% | $37.3M |
| Goods | ||
| RPPs & leases | ||
| Spare parts and services | ||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading